25
Participants
Start Date
May 23, 2019
Primary Completion Date
March 28, 2024
Study Completion Date
March 28, 2024
Resveratrol
Drug name: Micronised resveratrol. Dosage form: 500mg capsules. Alternate name: 1,3-Benzenediol, 5-\[2-(4-hydroxyphenyl)ethenyl\]-, (E). Ingredients: 99.50% pure trans-resveratrol. Placebo capsules will be identical in terms of taste, smell, and appearance.
Royal North Shore Hospital, St Leonards
Murdoch Children's Research Institute, Parkville
University of Queensland Centre for Clinical Research, Herston
Royal Perth Hospital, Perth
Lead Sponsor
Murdoch Childrens Research Institute
OTHER